Tacit Therapeutics, Inc.
South San Francisco, CA
- UEI
- Y14NBVGAEND8
- CAGE
- 8WUJ4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 329 Oyster Point Blvd, South San Francisco, CA 94080, USA
- Website
- tacittx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II: repurposing RNA processing factors to edit RNA for the treatment of dravet syndrome | National Science Foundation | $999,255 |
Quick answers
Is Tacit Therapeutics, Inc. registered in SAM.gov?
Yes. Tacit Therapeutics, Inc.'s SAM.gov registration is active through March 30, 2027.
What is Tacit Therapeutics, Inc.'s most recent federal award?
Tacit Therapeutics, Inc.'s most recent federal grant award is Sbir phase II: repurposing RNA processing factors to edit RNA for the treatment of dravet syndrome (2334756), from National Science Foundation, on January 15, 2024.
On GovTribe
See Tacit Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors